Kangji Medical Holdings
Kangji Medical Holdings, also known as Kangji Medical, is a prominent player in the medical device industry, headquartered in China (CN). Founded in 2001, the company has established itself as a leader in the development and manufacturing of advanced medical equipment, particularly in the fields of orthopaedics and surgical instruments. With a strong operational presence across Asia and expanding into international markets, Kangji Medical is renowned for its innovative products, including high-quality implants and surgical tools that enhance patient outcomes. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in healthcare. Kangji Medical's dedication to quality and innovation has earned it a notable reputation, making it a key contributor to the global medical device landscape.
DitchCarbon Score
How does Kangji Medical Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kangji Medical Holdings's score of 6 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kangji Medical Holdings's reported carbon emissions
In 2022, Kangji Medical Holdings reported total carbon emissions of approximately 3,471,020 kg CO2e, comprising 145,520 kg CO2e from Scope 1, 3,325,500 kg CO2e from Scope 2, and 3,471,020 kg CO2e from Scope 3 emissions. This marked an increase from 2021, where total emissions were about 2,712,360 kg CO2e, with Scope 1 emissions at 127,150 kg CO2e and Scope 2 emissions at 2,585,210 kg CO2e. In 2020, the company recorded total emissions of approximately 2,562,230 kg CO2e, with Scope 1 emissions at 180,480 kg CO2e and Scope 2 emissions at 2,381,760 kg CO2e. Despite these figures, Kangji Medical Holdings has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate pledges or science-based targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the medical industry increasingly prioritises sustainability, Kangji Medical Holdings will need to establish clear commitments to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 180,480 | 000,000 | 000,000 |
| Scope 2 | 2,381,760 | 0,000,000 | 0,000,000 |
| Scope 3 | 2,562,230 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kangji Medical Holdings is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
